Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • CLC bio partners with Ion Torrent to expand high-throughput sequencing support

    CLC bio, , today announced a partnership with Ion Torrent, a new sequencing company started by Dr. Jonathan Rothberg, the founder of 454 Life Sciences. The partnership will ensure that data can directly flow off of the Ion Personal Genome Machine (PGM™) sequencer and into CLC bio’s solutions, like CLC Genomics Workbench or CLC Genomics Server.

    "Our Ion PGM sequencer does a single run in about an hour, but for scientists to maintain a high-speed workflow with no bottlenecks it’s critical for scientists to have user-friendly analysis capacity,” said CEO and Chairman of Ion Torrent, Jonathan M. Rothberg, Ph.D. “CLC bio is one of the leading developers of high-throughput sequence data analysis
    software, so we are pleased for the opportunity to partner with them.”

    Ion Torrent uses a massively parallel semiconductor sequencing technology that detects nucleotide additions without using light, optics, or lasers. Instead, a base is called by simply detecting the release of hydrogen ions following nucleotide incorporation. The Ion PGM sequencer can do a run in about an hour, offers semiconductor scalability and is one tenth
    the price of other sequencers to buy and to run.

    Grant program
    Ion Torrent™ will award two Ion PGM sequencers in April 2010 through a grant program designed to help make DNA sequencing accessible to all scientists. CLC bio is supporting this effort by supplying a lifetime license for CLC Genomics Workbench to each of the two winning grantees. Read more about the grant program here: http://www.clcbio.com/link.php?id=140

Latest Articles

Collapse

  • seqadmin
    Current Approaches to Protein Sequencing
    by seqadmin


    Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
    04-04-2024, 04:25 PM
  • seqadmin
    Strategies for Sequencing Challenging Samples
    by seqadmin


    Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
    03-22-2024, 06:39 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 04-11-2024, 12:08 PM
0 responses
22 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-10-2024, 10:19 PM
0 responses
24 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-10-2024, 09:21 AM
0 responses
20 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-04-2024, 09:00 AM
0 responses
52 views
0 likes
Last Post seqadmin  
Working...
X